Menu
GeneBe

rs138198461

Variant summary

Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6BP7BS1BS2

The NM_006363.6(SEC23B):ā€‹c.1512T>Cā€‹(p.Asn504=) variant causes a splice region, synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00305 in 1,614,136 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: š‘“ 0.0026 ( 1 hom., cov: 32)
Exomes š‘“: 0.0031 ( 9 hom. )

Consequence

SEC23B
NM_006363.6 splice_region, synonymous

Scores

2
Splicing: ADA: 0.0001931
2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:8

Conservation

PhyloP100: 0.201
Variant links:
Genes affected
SEC23B (HGNC:10702): (SEC23 homolog B, COPII coat complex component) The protein encoded by this gene is a member of the SEC23 subfamily of the SEC23/SEC24 family, which is involved in vesicle trafficking. The encoded protein has similarity to yeast Sec23p component of COPII. COPII is the coat protein complex responsible for vesicle budding from the ER. The function of this gene product has been implicated in cargo selection and concentration. Multiple alternatively spliced transcript variants have been identified in this gene. [provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 20-18543019-T-C is Benign according to our data. Variant chr20-18543019-T-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 337797.We mark this variant Likely_benign, oryginal submissions are: {Benign=1, Likely_benign=5, Uncertain_significance=1}.
BP7
Synonymous conserved (PhyloP=0.201 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00255 (389/152258) while in subpopulation NFE AF= 0.00373 (254/68006). AF 95% confidence interval is 0.00336. There are 1 homozygotes in gnomad4. There are 186 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 9 AD,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SEC23BNM_006363.6 linkuse as main transcriptc.1512T>C p.Asn504= splice_region_variant, synonymous_variant 14/20 ENST00000650089.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SEC23BENST00000650089.1 linkuse as main transcriptc.1512T>C p.Asn504= splice_region_variant, synonymous_variant 14/20 NM_006363.6 P1

Frequencies

GnomAD3 genomes
AF:
0.00256
AC:
389
AN:
152140
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000410
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00255
Gnomad ASJ
AF:
0.0107
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00311
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00373
Gnomad OTH
AF:
0.00384
GnomAD3 exomes
AF:
0.00299
AC:
752
AN:
251464
Hom.:
4
AF XY:
0.00307
AC XY:
417
AN XY:
135902
show subpopulations
Gnomad AFR exome
AF:
0.000615
Gnomad AMR exome
AF:
0.00162
Gnomad ASJ exome
AF:
0.0124
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000294
Gnomad FIN exome
AF:
0.00314
Gnomad NFE exome
AF:
0.00407
Gnomad OTH exome
AF:
0.00342
GnomAD4 exome
AF:
0.00311
AC:
4542
AN:
1461878
Hom.:
9
Cov.:
32
AF XY:
0.00310
AC XY:
2256
AN XY:
727240
show subpopulations
Gnomad4 AFR exome
AF:
0.000568
Gnomad4 AMR exome
AF:
0.00163
Gnomad4 ASJ exome
AF:
0.0114
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000429
Gnomad4 FIN exome
AF:
0.00320
Gnomad4 NFE exome
AF:
0.00338
Gnomad4 OTH exome
AF:
0.00308
GnomAD4 genome
AF:
0.00255
AC:
389
AN:
152258
Hom.:
1
Cov.:
32
AF XY:
0.00250
AC XY:
186
AN XY:
74442
show subpopulations
Gnomad4 AFR
AF:
0.000409
Gnomad4 AMR
AF:
0.00255
Gnomad4 ASJ
AF:
0.0107
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000207
Gnomad4 FIN
AF:
0.00311
Gnomad4 NFE
AF:
0.00373
Gnomad4 OTH
AF:
0.00380
Alfa
AF:
0.00413
Hom.:
4
Bravo
AF:
0.00257
EpiCase
AF:
0.00300
EpiControl
AF:
0.00314

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:4
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024SEC23B: BP4, BP7 -
Uncertain significance, criteria provided, single submitterclinical testingMayo Clinic Laboratories, Mayo ClinicJan 26, 2023- -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesJun 15, 2023- -
Congenital dyserythropoietic anemia, type II Benign:2
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Likely benign, criteria provided, single submitterclinical testingMendelicsMay 28, 2019- -
not specified Benign:1
Likely benign, criteria provided, single submitterclinical testingInstitute for Genomic Medicine (IGM) Clinical Laboratory, Nationwide Children's HospitalMay 04, 2017BS1, BP7; This alteration has an allele frequency that is greater than expected for the associated disease, and is a synonymous alteration with no predicted impact on splicing and/or occurring at a non-evolutionarily conserved nucleotide position. -
Congenital dyserythropoietic anemia, type II;C4225179:Cowden syndrome 7 Benign:1
Benign, criteria provided, single submitterclinical testingInvitaeJan 31, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.53
CADD
Benign
8.4
DANN
Benign
0.77
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7

Splicing

Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
0.00019
dbscSNV1_RF
Benign
0.028
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs138198461; hg19: chr20-18523663; API